RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Stationary cycling for thinking and brain blood vessels

Researchers are testing aerobic exercise and measuring thinking and blood-vessel function in Parkinson's.

Testing a treatment or activity · Study reference: RBR-4yydrsg

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Results reported

Start (reported date)
2024-08-19
Study finished (reported date)
2026-03-01

Planned dates can move. A study finishing does not tell us when a paper will be published.

Read the results reported in the registry

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 40y to 0 · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: -

Inclusion criteria: Individuals of both sexes having a previous diagnosis of Parkinson's disease; be undergoing pharmacological treatment for PD; be at least 40 years old Exclusion criteria: Being in Hoehn & Yahr stages 4 and 5 of Parkinson's disease; have other neurological diseases in addition to Parkinson's disease; present a previous diagnosis of cardiovascular disease (except systemic arterial hypertension) or presence of symptoms suggestive of an unknown cardiovascular disease; inability to move independently without the aid of aids; present contraindications for aerobic training; be performing aerobic training regularly; have long COVID; severe cognitive impairment defined by a score lower than 18 on the Mini Mental State Examination
Full study name & original research details

Official study title

Effects of Aerobic Training on cerebrovascular and cognitive functions and gait of patients with Parkinson's Disease

Short title used by the registry

Effects of Aerobic Training performed on stationary bicycle on cognitive function and cerebrovascular blood vessel function in patients with Parkinson's Disease

Original description

Intervention: It is a single-blind randomized controlled clinical trial. 40 participants with Parkinson's disease will be randomly allocated into 2 groups: i) aerobic training and ii) control. In both groups, intervention sessions will be held 3 times a week for 12 weeks. Aerobic training sessions will include aerobic exercise on a cycle ergometer for 40 minutes at moderate intensity (12-13/20 points on the Borg scale). The control group will maintain usual care, including traditional motor rehabilitation sessions consisting of stretching, gait, balance and posture exercises and exercises with free weights, in addition to group activities (painting and choir).;G11.427.410.698.277 Primary outcome: It is expected to find a greater improvement in global cognition, verified by the Montreal Cognitive Assessment (MoCA) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0.05.;It is expected to find an improvement in the non-motor symptoms of Parkinson's disease, verified by the Non-Motor Symptom Assessment Scale in Parkinson's Disease (NMSS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0.05. Secondary outcome: It is expected to find an improvement in sleep quality, assessed by the Parkinson's Disease Sleep Scale (PDSS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a P value < 0.05.;It is expected to find an improvement in anxiety symptoms, assessed by the Parkinson Anxiety Scale (PAS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a P value < 0.05.;It is expected to find an improvement in depression symptoms, assessed by the Geriatric Depression Scale (GDS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0.05.;It is expected to find an improvement in apathy levels, assessed by the Apathy Inventory after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0, 05.;It is expected to find an improvement in fatigue levels, assessed by the Parkinson Fatigue Scale (PFS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0.05.;It is expected to find an improvement in pain intensity, assessed by the Numerical Rating Scale (NRS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0.05.;It is expected to find an improvement in quality of life, assessed by the Parkinson's Disease Questionnaire (PDQ-8) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a P value < 0.05.;It is expected to find an improvement in the clinical condition, assessed by the Unified Parkinson's Disease Rating Scale (UPDRS) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a P value < 0.05.;It is expected to find an improvement in gait, assessed by kinematic and kinetic aspects (joint angles, moments and powers) after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a P value < 0.05.;In comparison to the control group, it is expected to find an improvement in cerebrovascular function after aerobic training, assessed through transcranial Doppler considering as indices neurovascular coupling, cerebral autoregulation, vasomotor reactivity, acute cerebral blood flow response during aerobic exercise and basal cerebral blood flow. This effect will be verified through a statistically significant interaction between the factors group and time defined as a value of P < 0.05.;It is expected to find an improvement in cardiovascular autonomic modulation, assessed by the analysis of heart rate and blood pressure variability, after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and defined time as a P value < 0.05.;It is expected to find an improvement in resting blood pressure, assessed by the oscillometric method, after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0 .05.;It is expected to find an improvement in flow-mediated dilation, assessed by duplex ultrasound, after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0 .05.;It is expected to find an improvement in intima-media thickness , assessed by brightness mode ultrasound, after aerobic training in comparison to the control group, based on the finding of a statistically significant interaction between the factors group and time defined as a value of P < 0 .05.

Conditions reported: Parkinson Disease;C10.228

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
It is a single-blind randomized controlled clinical trial. 40 participants with Parkinson's disease will be randomly allocated into 2 groups: i) aerobic training and ii) control. In both groups, intervention sessions will be held 3 times a week for 12 weeks. Aerobic training sessions will include aerobic exercise on a cycle ergometer for 40 minutes at moderate intensity (12-13/20 points on the Borg scale). The control group will maintain usual care, including traditional motor rehabilitation sessions consisting of stretching, gait, balance and posture exercises and exercises with free weights, in addition to group activities (painting and choir).;G11.427.410.698.277
Phases
N/A
Sponsor
Universidade Nove de Julho
Start date reported by registry
2024-08-19 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Rafael Fecchio · +55(11)991814040 · rafael_fecchio@hotmail.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

Brazil

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.